Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. (EWTX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · EWTX · as of Jun 8, 2026
Activity summary
Buy transactions
1
P-Purchase only
Sell transactions
19
12 Months
Buy/Sell ratio
0.05
Buy/Sell (by trades)
Overall sentiment
Edgewise Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
EWTX insider buying and selling by quarter
EWTX insider selling · EWTX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · EWTX ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
EWTX executive sell shares · EWTX board member insider trading · EWTX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 5, 2026 | Donovan Joanne M. CMO | Option | 50,000 | $354K | Form 4 |
| May 5, 2026 | Donovan Joanne M. CMO | Sale | 50,000 | $1.93M⚡ | Form 4 |
| May 4, 2026 | Donovan Joanne M. CMO | Sale | 5,230 | $164K | Form 4 |
| Apr 1, 2026 | Fox Jonathan C Director | Award | 339 | — | Form 4 |
| Apr 1, 2026 | Donovan Joanne M. CMO | Option | 28,662 | $203K | Form 4 |
| Apr 1, 2026 | Donovan Joanne M. CMO | Sale | 28,662 | $926K | Form 4 |
| Mar 31, 2026 | Donovan Joanne M. CMO | Option | 21,338 | $151K | Form 4 |
| Mar 31, 2026 | Donovan Joanne M. CMO | Sale | 21,338 | $685K | Form 4 |
| Mar 27, 2026 | Donovan Joanne M. CMO | Sale | 9,623 | $298K | Form 4 |
| Mar 27, 2026 | Donovan Joanne M. CMO | Sale | 6,735 | $209K | Form 4 |
| Jan 21, 2026 | Edris Badreddin Director | Option | 7,605 | $5K | Form 4 |
| Jan 21, 2026 | Edris Badreddin Director | Option | 66,477 | $128K | Form 4 |
| Jan 21, 2026 | Edris Badreddin Director | Sale | 13,690 | $403K | Form 4 |
| Jan 21, 2026 | Edris Badreddin Director | Sale | 17,236 | $507K | Form 4 |
| Jan 21, 2026 | Edris Badreddin Director | Sale | 7,605 | $224K | Form 4 |
| Jan 21, 2026 | Edris Badreddin Director | Sale | 10,463 | $308K | Form 4 |
| Jan 21, 2026 | Edris Badreddin Director | Option | 10,463 | $20K | Form 4 |
| Jan 21, 2026 | Edris Badreddin Director | Option | 17,236 | $11K | Form 4 |
| Jan 21, 2026 | Edris Badreddin Director | Option | 13,690 | $5K | Form 4 |
| Jan 21, 2026 | Edris Badreddin Director | Sale | 66,477 | $1.96M⚡ | Form 4 |
| Jan 2, 2026 | Fox Jonathan C Director | Award | 473 | — | Form 4 |
| Nov 12, 2025 | Russell Alan J Chief Scientific Officer · Director | Option | 100,000 | $18K | Form 4 |
| Nov 12, 2025 | Russell Alan J Chief Scientific Officer · Director | Sale | 100,000 | $2.11M⚡ | Form 4 |
| Nov 11, 2025 | Fox Jonathan C Director | Purchase | 10,700 | $199K | Form 4 |
| Oct 1, 2025 | Fox Jonathan C Director | Award | 728 | — | Form 4 |
Russell Alan J
Chief Scientific Officer · Director
Date
Nov 12
Shares
100,000
Price
$0.18
Value
$18K
Russell Alan J
Chief Scientific Officer · Director
Date
Nov 12
Shares
100,000
Price
$21.12
Value
$2.11M ⚡
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About EWTX insider trading
EWTX insider trades
Edgewise Therapeutics, Inc. (EWTX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Donovan Joanne M. (CMO), Edris Badreddin (Director), Russell Alan J (Chief Scientific Officer · Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. EWTX insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Edgewise Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
EWTX insider trading · 5 questionsThe insiders of Edgewise Therapeutics, Inc. (EWTX) include executives and directors such as Donovan Joanne M. (CMO), Edris Badreddin (Director), Russell Alan J (Chief Scientific Officer · Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026